Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Scientific Reports|June 22, 2017
Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's diseaseFang Fang, Wanlin Yang, Jazmin B Florio, et al.
Science Translational Medicine|June 7, 2019
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathologyJuan A Gerez, Natalia C Prymaczok, Edward Rockenstein, et al.
Human Molecular Genetics|April 30, 2016
Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's diseaseEdward Rockenstein, Jennifer Clarke, Catherine Viel, et al.
Neurobiology of Disease|November 28, 2015
HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disordersJerel Adam Fields, Elisabeth Serger, Sofia Campos, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 20, 2020
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy BodiesJulia Marschallinger, Barbara Altendorfer, Edward Rockenstein, et al.
Plos One|May 12, 2011
Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body diseaseEliezer Masliah, Edward Rockenstein, Michael Mante, et al.
NPJ Vaccines|January 11, 2022
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studiesChangyoun Kim, Armine Hovakimyan, Karen Zagorski, et al.
Brain : a Journal of Neurology|March 26, 2014
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivoEdward Rockenstein, Silke Nuber, Cassia R Overk, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Polyamine pathway contributes to the pathogenesis of Parkinson diseaseNicole M Lewandowski, Shulin Ju, Miguel Verbitsky, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Scientific Reports|June 22, 2017
Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's diseaseFang Fang, Wanlin Yang, Jazmin B Florio, et al.
Science Translational Medicine|June 7, 2019
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathologyJuan A Gerez, Natalia C Prymaczok, Edward Rockenstein, et al.
Human Molecular Genetics|April 30, 2016
Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's diseaseEdward Rockenstein, Jennifer Clarke, Catherine Viel, et al.
Neurobiology of Disease|November 28, 2015
HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disordersJerel Adam Fields, Elisabeth Serger, Sofia Campos, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 20, 2020
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy BodiesJulia Marschallinger, Barbara Altendorfer, Edward Rockenstein, et al.
Plos One|May 12, 2011
Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body diseaseEliezer Masliah, Edward Rockenstein, Michael Mante, et al.
NPJ Vaccines|January 11, 2022
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studiesChangyoun Kim, Armine Hovakimyan, Karen Zagorski, et al.
Brain : a Journal of Neurology|March 26, 2014
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivoEdward Rockenstein, Silke Nuber, Cassia R Overk, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Polyamine pathway contributes to the pathogenesis of Parkinson diseaseNicole M Lewandowski, Shulin Ju, Miguel Verbitsky, et al.
Pageof 17